Whether you're looking to raise capital in the financial markets to expand your business or simply elevate its public profile, we have the experience and knowledge to navigate you through the process of listing business. We also provide crucial ongoing advice to companies already operating in the public arena.

Clients need the highest quality service in an ever-evolving legal and regulatory environment. Our team has genuine sector expertise, meaning we can respond to the specific needs and character of clients in a wide variety of sectors.

Transactions often involve a cross-border element, which requires a co-ordinated and unified approach from our international network of offices. Our advice covers the full range of equity financing transactions including initial public offerings on key international exchanges (including London, Australia, Hong Kong and Singapore), rights issues, placings and other secondary offerings, capital reorganisations, reverse takeovers and public takeovers and mergers.

We routinely act for issuers, investment banks and underwriters, bookrunners, sponsors, nominated advisers, management teams and shareholders on a wide range of equity market transactions.

Recent highlights of work


Related Materials: UK PLC Updates

April 2018: ESMA publishes proposed new rules on the format, content, scrutiny and approval of prospectuses

April 2018: AIM given SME Growth Market Status Implications for AIM Companies

April 2018: Financial Reporting Council's Consultation on changes to The UK Corporate Governance Code

April 2018: Pre-emption Group expectations regarding share disapplication threshold

September 2018: Preparation for Corporate Governance Changes for AIM companies

September 2018: Increase in total size of public offers exempt from requirement to publish prospectus

September 2018: AFME and Euro IRP issue guidance on new FCA rules requiring issuer access for unconnected analysts

September 2018: The UK Corporate Governance Code 2018

June 2019: New Prospectus Regulation – Final Implementation

June 2019: FCA Competition Enforcement

June 2019: AIM Corporate Governance – A Survey of Codes

June 2019: AIM Disciplinary Notice

December 2019: New ESMA Guidelines on Risk Factors in Prospectuses come into force

December 2019: Shareholders' Rights Directive II – implications for Listed Companies

December 2019: QCA Publish Updated Audit Committee Guide

December 2019: FCA review of unbundling of research costs under MiFID II

April 2021: Review of UK Listing Regime

April 2021: Medicinal Cannabis Companies begin to list on London Stock Exchange

April 2021: New Climate related Disclosure Requirements for Listed Companies

April 2021: New major shareholdings notification portal announced

April 2021: Proposed new UK foreign investment and listing restrictions


News & Events